@raphaels7 @AmandaCLeiter Sorry, I'm probably the wrong person. But type 1 diabetes falls under "endocrinopathy" as used in this review in nature and are acutally termed "chronic". https://t.co/1ri0e6eA3r I guess, even when the immune attack on the beta ce
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @TakaMatsuo_ID: 【Frequencies of chronic immune-checkpoint inhibitor-induced toxicities】 https://t.co/nxEcLG5GoZ
https://t.co/WNrwzgUGev $nwbo @alphavestcap
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @leafs_s: RT @ target="_blank" href="mailto:CastlTrAstonDrs[email protected]">@med-mastodon.com">[email protected] 🎄Recap Nature #Clinicaloncology #Clinicalreviews current evidence for chronic immune toxi…
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
Inhibidores del punto de control inmunitario: implicaciones a largo plazo de la toxicidad https://t.co/UxjQ1T7DME
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @TakaMatsuo_ID: 【Frequencies of chronic immune-checkpoint inhibitor-induced toxicities】 https://t.co/nxEcLG5GoZ
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
【Frequencies of chronic immune-checkpoint inhibitor-induced toxicities】 https://t.co/nxEcLG5GoZ
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
Immune-checkpoint inhibitors: long-term implications of toxicity | Nature Reviews Clinical Oncology https://t.co/2bpjG1fOBh
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @alphavestcap: https://t.co/WNrwzgUGev $nwbo @alphavestcap
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
https://t.co/WNrwzgUGev $nwbo @alphavestcap
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
A very good review
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
ICIs
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w
RT @NatRevClinOncol: The #7 most visited long article published in @natrevclinoncol in 2022 is: https://t.co/cgr33V2W2w